All Janssen HME Forum webinars

How do you plan the patient journey at diagnosis for patients with multiple myeloma?

28 April 2022 - 45 Minutes

Faculty

María Victoria Mateos

Philippe Moreau

Inger Nijhof

EM-78398

Is cure attainable in patients with multiple myeloma?

26 April 2022 - 45 Minutes

Faculty

Mohamad Mohty

Rakesh Popat

EM-78392

Challenges in NHL: Future strategies and new treatment algorithms in MCL

7 April 2022 - 53 Minutes

Faculty

Georg Hess

Ana Marín Niebla

EM-78663

Challenges in CLL: Standards of care or precision medicine: what applies in CLL?

29 March 2022 - 46 Minutes

Faculty

John Gribben

Carol Moreno

Paolo Ghia

EM-78435

Challenges in NHL: Management of WM in the era of BTKis

15 March 2022 - 50 Minutes

Faculty

Christian Buske

Steve Treon

Ramon Garcia-Sanz

EM-78658

Transforming the landscape of multiple myeloma (MM) with CAR T-cell therapies

12 March 2022 - 46 Minutes

Faculty

Philippe Moreau

Kwee Yong

Inger Nijhof

EM-89024

Patient management strategies with CAR T-cell therapies in multiple myeloma: How to prepare the patient

10 March 2022 - 52 Minutes

Faculty

Paula Rodriguez Otero

Salomon Manier

Jaime Gállego Pérez-Larraya

EM-78389

Is fixed-duration therapy realistic in managing patients with multiple myeloma?

8 March 2022 - 47 Minutes

Faculty

Mohamad Mohty

Philippe Moreau

EM-78385

Challenges in CLL: Using biology to guide first-line treatment

1 March 2022 - 48 Minutes

Faculty

Kostas Stamatopoulos

Gianluca Gaidano

Florence Cymbalista

Is ASCT still the standard of care in fit patients with newly-diagnosed multiple myeloma?

24 February 2022 - 46 Minutes

Faculty

Xavier Leleu

Mohamad Mohty

1
2
3
4
5
6
7